의학기술  제조업체, 딜러, 공급업체

40 years of top-quality medical engineering
The pfm medical Group comprises several distribution and manufacturing companies; its more than 400 employees are spread across four continents. Our main office is located in Cologne, an important centre for medical engineering in Germany.
pfm medical was founded in 1971 by Jürgen Wolter as 'pfm Plastik für die Medizin GmbH'. The continuing corporate success is based on our consistent focus on outstanding quality. Our portfolio was developed based on our many years of experience and reflects major areas of application in medical practice: Histotechnology, Therapy Management, OR Services, Surgical Implants and Cardio Vascular Technologies.
We distribute our very own products as well as products by leading international manufacturers in more than 100 countries across the globe – many of them exclusively. If necessary, we work on improving them with the manufacturer in a cooperation based on mutual trust.
Wherever we recognise a potential for innovations, our own research and development enters the market with determination. For example, this means the development of innovative specialised products for regional tumour therapy, interventional procedures in radiology and both adult and paediatric cardiology.
This commitment to the highest standards of quality combined with 40 years of experience have made pfm medical one of the leading international partners for medical products.

우리는 자체 개발, 생산, 판매 및 서비스를 소유한 가족 기업이다. 10년 이상 우리는 의학 실험실에 샘플 수신 및 사전 분석 솔루션을 성공적으로 제공해왔다. 우리의 핵심 제품인 아틀라스 분류기는 트레이 및 랙까지 안전하고 신속하게 등록하고 분류할 수 있다. T&O LabSystems는 샘플을 실험실로 운송하는 혁신적인 개념과 개별 샘플의 지능형 컨베이어 벨트를 통해 우리의 제품 범위를 확장하여 검수에서 분석에 이르는 물류에 대한 솔루션을 제공한다. T&O Lab Systems는 고도의 기술력과 혁신성을 바탕으로 전 세계에 450대 이상의 장비를 설치하고 OEM 분야에서 많은 협력을 하고 있으며, 의학 연구소와 회사의 믿을 수 있는 파트너가 되었다. 우리는 고객, 동료, 파트너와 판매 파트너와의 공평하고 융통성 있는 거래를 중시하는데, 왜냐하면 우리는 지속가능한 비즈니스 관계가 기업의 장기적인 성공과 고객 만족의 기초라고 믿기 때문이다.

ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. In the past fiscal year, the ZEISS Group generated annual revenue totaling 6.3 billion euros in the four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets, and invested 13 percent of its revenue in research and development (as of 30 September 2020). ZEISS has a long tradition of similarly high expenditures for research and development, which also represent an investment in the future.
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.Over 32,000 employees in almost 50 countries work at around 30 production sites, 60 sales and service locations and 27 research and development facilities. The company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.